key: cord-1010448-aq0m3ooc
authors: Zekri, Abdel-Rahman N.; Easa Amer, Khaled; Hafez, Mohammed M; Hassan, Zeinab K.; Ahmed, Ola S; Soliman, Hany K.; Bahnasy, Abeer A.; Abdel Hamid, Wael; Gad, Ahmad; Ali, Mahmoud; Hassan, Wael; Samir, Mahmoud; Raouf, Ahmad; Khattab, Ayman A.; Salah El Din Hamdy, Mona; Sherif Soliman, May; Hamdi El Sissy, Maha; Mohamed El khateeb, Sara; Hosny Ezzelarab, Moushira; Fathalla, Lamiaa A; Abouelhoda, Mohamed
title: Genomic characterization of SARS-CoV-2 in Egypt
date: 2020-11-26
journal: J Adv Res
DOI: 10.1016/j.jare.2020.11.012
sha: 98a2ba7bd435c4e00b93d5d9e4b064a966489891
doc_id: 1010448
cord_uid: aq0m3ooc

Introduction The novel coronavirus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread throughout the globe, causing a pandemic. In Egypt over 96,108 individuals were infected so far. Objective In the present study, the objective is to perform a complete genome sequence of SAR-CoV2 isolated from Egyptian coronavirus disease (COVID-19) patients. Methods Nasopharyngeal swabs were collected from 61 COVID-19 patients who attended at National Cancer Institute, Kasr Al-Aini Hospital and the army hospital. Viral RNA was extracted and whole genomic sequencing was conducted using Next Generation Sequencing. Results In all cases, the sequenced virus has at least 99% identity to the reference Wuhan 1. The sequence analysis showed 204 distinct genome variations including 114 missense mutations, 72 synonymous mutations, 1 disruptive in-frame deletion, 7 downstream gene mutations, 6 upstream gene mutations, 3 frame-shift deletions, and 1 in-frame deletion. The most dominant clades were G/GH/GR/O and the dominant type is B. Conclusion The whole genomic sequence of SARS-CoV2 showed 204 variations in the genomes of the Egyptian isolates, where the Asp614Gly (D614G) substitution is the most common among the samples (60/61). So far, there were no strikingly variations specific to the Egyptian population, at least for this set of samples.

An outbreak of a viral respiratory illness (officially named by the World Health Organization 53 coronavirus disease, COVID-19) started around mid-December 2019, in the city of Wuhan, 54 Hubei province, China. The COVID-19 is an infectious disease of the respiratory tract triggered 55 by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) which in severe cases 56 can lead to acute respiratory distress syndrome and death [1] . The disease has rapidly spread 57 to the entire world [2] . On March 11, 2020, the WHO declared COVID-19 to be pandemic. 58 Now, more than 20,730,456 confirmed cases of COVID-19, including 751,154 deaths have 59 been reported worldwide according to WHO. 60 The SARS-CoV-2 genome size varies from 29.8 to 29.9 kb and the 5′ region represent more 61 than two-thirds of the genome that comprises open reading frame (ORF1ab) encoding ORF1ab 62 polyproteins, while the 3′ one third consists of genes encoding structural proteins including 63 surface (S), envelope (E), membrane (M), and nucleocapsid (N) proteins. The SARS-CoV-2 64 comprises 6 accessory proteins, encoded by ORF3a, ORF6, ORF7a, ORF7b, and ORF8 [3, 4] . 65 To date, by genetic homogeneity the closest virus phylogenetically to SARS-CoV-2 is a 66 coronavirus isolated from the horseshoe bat (Bat CoV RaTG13) with an overall genome 67 sequence identity of 96.2 % , which is higher than that of SARS-CoV (<80 % ) [5, 6] . 68 Next generation sequencing provides high-quality, full-scale genome sequences for viral 69 isolates collected in relatively non-biased ways, irrespective of virulence or other unusual 70 properties. Analyzes of the genome sequences gave insight into the pattern of global 71 distribution, the genetic diversity during epidemics and the dynamics of the development of 72 subtypes. SARS-CoV2 database, such as GISAID (www.gisaid.org), the NCBI SARS-CoV2 73 database (https://www.ncbi.nlm.nih.gov/sars-cov-2), and NGDC Genome Warehouse 74 (https://bigd.big.ac.cn/gwh/), make the genomic information publicly available, together with 75 epidemiological data for the sequenced isolates. 76 The development of a statistical system focused on epidemiological, antigenic and genetic 77 knowledge may provide more insight into the rules regulating the appearance and development 78 of antigenically novel mutations and improve the capacity for prevention and regulation of 79 SARS-CoV2 [7, 8] . Studies strongly support an urgent necessity for additional rapid, wide-80 ranging investigations that incorporate genetic data, epidemiological knowledge and graph 81 details of patients with COVID-19 with clinical characteristics [9, 10] . Therefore, we studied the molecular variation among SARS-CoV-2 genomes isolated and sequenced from COVID-83 19 Egyptian patients. calling of the raw data. Two strategies were utilized for genome assembly and these were 126 executed in two independent tracks: The first is de-novo assembly, where the reads were 127 assembled using the IRMA (v0.9.3) workflow. The second is based on reference-based 128 assembly, where the reads were assembled by mapping (aligning) them to a reference genome.

The tmap program (v.512) was used to align the reads to the reference corona virus genome 130 Wuhan 1 (RefSeq; NC_045512.2). The consensus sequence was then computed from the 131 aligned reads. After finishing the assembly, the de-novo assembly was compared against the 132 reference-based assembly to assure consistency of the results. In fact, for this target amplicon 133 based panel, we see that the reference-based assembly is enough to reconstruct the viral 134 sequence. Samples with less than 99% coverage or with gaps larger than 30 bps were excluded.

The final successful set included 61 complete genome sequences and these were uploaded to 136 NCBI/GISAID repositories (Supplementary File S1).

Preparing world datasets: All the complete SARS-CoV2 genome sequences were first retrieved 138 from the GISAID website on 30 June 2020 and all sequences with long internal gaps or 139 ambiguities (larger than 30bps) were excluded. The final dataset included 46,612 sequences.

On October 2020, we updated this dataset and the number of sequences increased to 89632. On 141 these sequences, the following processing was conducted to create different collections of Egyptian dataset: The variations (mutations) in the Egyptian genomes were examined for 187 quality and depth. A variation is filtered out if its depth is less than 50 reads. It is also filtered 188 out if its depth is less than 100, appears only once in our dataset, and did not appear in world Table 5, shows the  contingency table for the variations in Table 3 and the sub-populations listed above. For 207 comparing the distribution of variations in the set of virus genes (Table 2) , we also used Chi 208 square test. The P-value threshold 0.05 is used to confirm or reject differences between the 209 variables in the test. Specifically, P-value > 0.05 means that there is no difference between the 210 two sub-populations (two groups) with respect to the variations (categories) at hand. In this study, three frameshift mutations were detected, one of which was detected in ORF1ab, (Table 1) . that most of the variegations (148 ones) are in the ORF part due to its size (Figure 1 b) . We 266 compared this pattern of distribution in Egyptian world datasets. Chi square).

The table also shows the ratio between the synonymous and non-synonymous mutations in Table 3 lists these variations and their frequencies in world and regional 290 datasets. It is interesting to note that these variations are also abundant in the world and regional sub-sampled from the Nextstrain (Figure 2 ). The tree shows that most of the Egyptian cohorts of 313 samples can be assigned clades G/GR/GH/O (as per GISAID system). in to see the sequence information https://github.com/mabouelhoda/nCovEgypt.

In detail, the phylogenetic study of the full sequences ( Figure 3) of the S1 domain [24, 25] . This mutation with residual glycine 614 (G614) was previously detected 409 to increase at an alarming rate and were observed at low frequency in March (26%), but increased 

The replicase enzyme is shown as two polyproteins (ORF1a and ORF1ab) [27, 28] States of America. One sample was identical to the one from Sweden, England and Israel. One 482 sample was identical to that from the United States of America, Saudi Arabia, India and Colombia.

One sample was the same as that collected from Saudi Arabia.

In conclusion, we detect 204 unique sequence variations in genomes isolated from Egyptian 

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2): An 507

COVID-19): a systematic review of chest 509 CT findings in 4410 adult patients

Full-genome sequences of the first two SARS-CoV-2 viruses from 511

Genotype and phenotype of COVID-19: Their roles in 513 pathogenesis

Functional assessment of cell entry and receptor 515 usage for SARS-CoV-2 and other lineage B betacoronaviruses

Identification of SARS-like coronaviruses in horseshoe bats 518 (Rhinolophus hipposideros) in Slovenia

Isolation and characterization of a bat SARS-like coronavirus that uses the 520 ACE2 receptor

Isolation and Characterization of a Novel Bat Coronavirus Closely 522

Related to the Direct Progenitor of Severe Acute Respiratory Syndrome Coronavirus

Establishment of a basic medical science system for 13

Versatile and open software for comparing large genomes

A program for annotating and predicting the effects of single 537 nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain 538 w1118; iso-2; iso-3. Fly (Austin)

T cell responses to whole SARS coronavirus in humans

Comparative full-length genome sequence analysis of 14 SARS 542 coronavirus isolates and common mutations associated with putative origins of infection

The Genome sequence of the SARS-associated coronavirus

A 193-amino acid fragment of the SARS coronavirus S protein 547 efficiently binds angiotensin-converting enzyme 2

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis 550 Based on Decade-Long Structural Studies of SARS Coronavirus

The membrane protein of severe acute respiratory syndrome coronavirus acts 552 as a dominant immunogen revealed by a clustering region of novel functionally and 553 structurally defined cytotoxic T-lymphocyte epitopes

SARS-CoV-2 viral spike G614 mutation exhibits 556 higher case fatality rate

Variant analysis of SARS-CoV-2 genomes. Bull 558 World Health Organ

Exploring the genomic and proteomic variations of SARS-CoV-2 560 spike glycoprotein: A computational biology approach

Characterizations of SARS-CoV-2 mutational profile, spike protein 563 stability and viral transmission

Molecular characterization of SARS-CoV-2 in the first COVID-19 cluster 565

in France reveals an amino acid deletion in nsp2 (Asp268del)

The D614G mutation in the SARS-CoV-2 spike protein reduces S1 568 shedding and increases infectivity. bioRxiv, 2020. 569 27. van der Meer

Structure of the SARS-CoV nsp12 polymerase bound 574 to nsp7 and nsp8 co-factors

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G

Increases Infectivity of the COVID-19 Virus

The establishment of reference sequence for SARS-CoV-2 and variation 578 analysis

Severe acute respiratory syndrome coronavirus nonstructural 580 proteins 3, 4, and 6 induce double-membrane vesicles. mBio

Structural Basis for RNA Replication by the SARS-CoV-2 Polymerase

Genotyping coronavirus SARS-CoV-2: methods and implications

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

Emerging SARS-CoV-2 mutation hot spots include a novel RNA-28

of Cairo University for his support of this work. Also the authors' thank go to Science and 490 Technology Development Fund (STDF) (ACSE41907).

.

Conflict of interests: The authors declare that there is no conflict of interests.

Author contributions 494 AZ participated in study conceptualization, study design, interpreting the data analysis,